Implementing partners with past or current USAID-funded pilots: MCSP/Jhpiego, Marie Stopes International (MSI)*, Population Services International/Society for Family Health, and WCG Cares. Data collection is ongoing for some programs; this dashboard will be updated periodically.*MSI is not currently a recipient of USAID funding

M&E data included here for a sub-set of these countries.

Zimbabwe

Madagascar

Zambia

Nigeria

Q. IF THE LNG-IUS HAD NOT BEEN AVAILABLE TODAY, WHAT METHOD, IF ANY, WOULD YOU HAVE CHOSEN INSTEAD?

Across almost all countries, the majority of LNG-IUS users report that they would have used another long-acting reversible contraceptive (copper IUD or implants) if the LNG-IUS had not been available. However, a portion in every country would have selected a shorter-acting, less effective method instead. The LNG-IUS may provide an option for women who desire a highly effective, long-acting method and who do not find the attributes of the other long-acting methods acceptable.

PILOT INTRODUCTIONS OF THE LEVONORGESTRELINTRAUTERINE SYSTEM (LNG-IUS)

i 2 responses missing from original sample of 287

ii 7 responses missing from original sample of n=1013

iii 31 responses missing from original sample of n=362

Kenya

Copper IUD

Implant

Injectable

Pills

Other

Condom

No method

Sterilization

Gone elsewhere for LNG-IUS

Jhpiego Kenya (n=285)i

Jhpiego Zambia (n=278)ii

SFH Zambia (n= 633)

SFHNigeria (n=1006)ii

MSI Nigeria (n=331)iii

PSIMadagascar (n=44)

Perspectives of LNG-IUS Users Across Introduction Programs

APRIL 2019

0%

20%

40%

60%

80%

100%

Q. WHAT WAS THE MAIN REASON YOU CHOSE AN LNG-IUS TODAY INSTEAD OF ANOTHER METHOD?

Jhpiego Kenya (n=285)v

SFH Nigeria (n=1006)vi

Q. WHAT REASONS DID YOU CHOSE AN LNG-IUS TODAY INSTEAD OF ANOTHER METHOD?

iv Respondents spontaneously mentioned responses. Multiple responses possible. Total n does not equal total sample size.

Jhpiego Zambia(n=278)iv

SFH Zambia (n= 633)iv

PSI Madagascar (n=44)iv

MSI Nigeria(n=362)iv

10% 20% 30% 40% 50% 60% 70% 80%

Long-acting

Effectiveness

Fewer side effects

Delay pregnancy

Reduces bleeding

Reversible

Don't wantmore children

Discreet

Other

Recommended

Ok when breastfeeding

Affordable

Convenient Across the countries, women’s most commonly reported reasons for choosing the LNG-IUS included its effectiveness, long-acting duration, reduced bleeding, fewer side effects and ability to use discreetly.

ReversibleOnce in place, no need to do anything

Delay pregnancyOtherDiscreet

Recommended

Long-actingEffectivenessFewer side effects

Reduces bleeding

Don't want more children

Doesn't affect future fertility

v 2 responses missing from original sample of 287 vi 7 responses missing from original sample of n=1013

APRIL 2019

Questions were administered by providers to clients who selected the LNG-IUS at the time of provision. Due to challenges in getting all providers to collect the data, questions were only administered to a sub-sample of LNG-IUS users in most cases. As such, the number of respondents does not reflect the full number of LNG-IUS units provided.